Sarcopenic obesity and weight loss-induced muscle mass loss DOI
Alfredo Caturano, Anastassia Amaro, Cesare Berra

et al.

Current Opinion in Clinical Nutrition & Metabolic Care, Journal Year: 2025, Volume and Issue: unknown

Published: April 23, 2025

Purpose of review Sarcopenic obesity is a clinical condition characterized by the coexistence excess adiposity and impaired muscle function, associated with heightened cardiometabolic risk frailty. The emergence new incretin-based management medications (OMMs), which allow unprecedented weight loss, has raised concerns regarding loss-induced fat-free mass (FFM) reduction, including skeletal (SMM). This examines recent findings on prevalence, diagnosis, implications sarcopenic obesity, explores effects weight-loss interventions body composition their impact health, discusses strategies to preserve mass. Recent Weight loss induced OMMs results in variable but significant reduction FFM. extent this affects SMM function remains uncertain. Nutritional strategies, particularly adequate protein intake, structured exercise interventions, especially resistance training, play key role mitigating FFM loss. Digital health telemedicine-based programs offer promising approaches for maintaining during Summary significance debated. Future research should refine diagnostic criteria, assess long-term FFM/SMM intentional evaluate that optimize while preserving functional health.

Language: Английский

Air pollution increases the risk of frailty: China Health and Retirement Longitudinal Study (CHARLS) DOI
Yuquan Chen,

Zhihu Xu,

Yuming Guo

et al.

Journal of Hazardous Materials, Journal Year: 2025, Volume and Issue: unknown, P. 138105 - 138105

Published: March 1, 2025

Language: Английский

Citations

1
Editor”s view—Safety first: optimising treatment modalities DOI
Nathalie van der Velde

Age and Ageing, Journal Year: 2025, Volume and Issue: 54(2)

Published: Feb. 1, 2025

Language: Английский

Citations

0
Sarcopenic obesity and weight loss-induced muscle mass loss DOI
Alfredo Caturano, Anastassia Amaro, Cesare Berra

et al.

Current Opinion in Clinical Nutrition & Metabolic Care, Journal Year: 2025, Volume and Issue: unknown

Published: April 23, 2025

Purpose of review Sarcopenic obesity is a clinical condition characterized by the coexistence excess adiposity and impaired muscle function, associated with heightened cardiometabolic risk frailty. The emergence new incretin-based management medications (OMMs), which allow unprecedented weight loss, has raised concerns regarding loss-induced fat-free mass (FFM) reduction, including skeletal (SMM). This examines recent findings on prevalence, diagnosis, implications sarcopenic obesity, explores effects weight-loss interventions body composition their impact health, discusses strategies to preserve mass. Recent Weight loss induced OMMs results in variable but significant reduction FFM. extent this affects SMM function remains uncertain. Nutritional strategies, particularly adequate protein intake, structured exercise interventions, especially resistance training, play key role mitigating FFM loss. Digital health telemedicine-based programs offer promising approaches for maintaining during Summary significance debated. Future research should refine diagnostic criteria, assess long-term FFM/SMM intentional evaluate that optimize while preserving functional health.

Language: Английский

Citations

0